The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 13,501–13,600 of 31,469
A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study
Pοlyzos, S. A., Kountouras, J., Slavakis, A., Zafeiriadou, E., Patsiaoura, K., Katsiki, E., Zavos, C., Παπαθεοδώρου, Α., & Terpos, E. (2013) · Biomarkers · doi:10.3109/1354750x.2013.838305 · Cited by 24
Kim, C., Kim, H., Kim, E., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0649-0 · Cited by 24
Effect of weight loss on central systolic blood pressure in elderly community-dwelling persons
Kawamoto, R., Kohara, K., Katoh, T., Kusunoki, T., Ohtsuka, N., Abe, M., Kumagi, T., & Miki, T. (2014) · Hypertension Research · doi:10.1038/hr.2014.108 · Cited by 23
Şıklar, Z., Berberoğlu, M., Çamtosun, E., & Kocaay, P. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.05.006 · Cited by 24
Oh, T. J., Min, S. H., Ahn, C. H., Kim, E. K., Kwak, S. H., Jung, H. S., Park, K. S., & Cho, Y. M. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.2.147 · Cited by 29
Catalano, D., Trovato, G. M., Martines, G. F., Pirri, C., & Trovato, F. M. (2011) · Hepatology International · doi:10.1007/s12072-011-9254-2 · Cited by 24
Elenkova, A. P., Matrozova, J., Zacharieva, S., Кirilov, G., & Kalinov, K. (2010) · Cytokine · doi:10.1016/j.cyto.2010.03.011 · Cited by 23
Khan, U. I., Wang, D., Karvonen-Gutierrez, C. A., Khalil, N., Ylitalo, K. R., & Santoro, N. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3259 · Cited by 26
Patel, D. A., Srinivasan, S. R., Chen, W., & Berenson, G. S. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0086 · Cited by 24
Associations of Plasma Homocysteine Levels with Arterial Stiffness in Prehypertensive Individuals
Kim, B. J., Seo, M. H., Huh, J. K., Kwon, C. H., Kim, J. T., Sung, K., Kim, B. S., & Kang, J. H. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.549274 · Cited by 24
Insulin Resistance in Women with Recurrent Spontaneous Miscarriage of Unknown Aetiology
Diejomaoh, M., Jirous, J., Al‐Azemi, M., Gupta, M., Al-Jaber, M., Farhat, R., & Mohd, A. T. (2007) · Medical Principles and Practice · doi:10.1159/000098363 · Cited by 24
Lekva, T., Michelsen, A. E., Bollerslev, J., Norwitz, E. R., Aukrust, P., Henriksen, T., & Ueland, T. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0345-1 · Cited by 26
Rastović, M., Srdić, B., Barak, O. F., & Stokić, E. (2016) · Nutrition & Dietetics · doi:10.1111/1747-0080.12280 · Cited by 24
Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children
Sakka, S. D., Siahanidou, T., Voyatzis, C., et al. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1081 · Cited by 24
Association Between Flavonoid-Rich Fruit and Vegetable Consumption and Total Serum Bilirubin
Loprinzi, P. D., & Mahoney, S. E. (2014) · Angiology · doi:10.1177/0003319714537111 · Cited by 24
Song, D. S., Chang, U. I., Choi, S., Jung, Y. D., Han, K., Ko, S., Ahn, Y., & Yang, J. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163222 · Cited by 24
Magdy, Y., El-Kharashi, O. A., Nabih, E. S., Shaker, S. M., Abd-Elaziz, L. F., & Aboul‐Fotouh, S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.098 · Cited by 24
Ponte, C. M. M., Fernandes, V. O., Castelo, M. H. C. G., Vasconcelos, I. T. G. F., Karbage, L. B. D. A. S., Liberato, C. B. R., Negrato, C. A., Gomes, M. B., Montenegro, A. P. D. R., & Montenegro, R. M. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0738-4 · Cited by 24
Garcés‐Rimón, M., González, C., Vera, G., Uranga, J. A., López‐Fandiño, R., López‐Miranda, V., & Miguel, M. (2018) · Nutrients · doi:10.3390/nu10040441 · Cited by 24
Yoon, K., Ryu, S., Lee, J.-E., & Park, J. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.06.008 · Cited by 24
Moen, G.-H., Qvigstad, E., Birkeland, K. I., Evans, D. M., & Sommer, C. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy101 · Cited by 23
Yoo, J.-Y., & Yum, K. (2018) · BioMed Research International · doi:10.1155/2018/1613247 · Cited by 24
Drummen, M., Dorenbos, E., Vreugdenhil, A. C. E., Raben, A., Fogelholm, M., Westerterp‐Plantenga, M. S., & Adam, T. C. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00162.2018 · Cited by 26
Spratlen, M. J., Grau-Pérez, M., Umans, J. G., Yracheta, J., Best, L. G., Francesconi, K. A., Goessler, W., Bottiglieri, T., Gamble, M. V., Cole, S. A., et al. (2018) · Environmental Research · doi:10.1016/j.envres.2018.09.034 · Cited by 25
Głuszewska, A., Gryglewska, B., Gąsowski, J., Bilo, G., Zarzycki, B., Dzieza-Grudnik, A., Major, P., Budzynski, A. Z., Faini, A., Parati, G., et al. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.10.022 · Cited by 24
Omentin‐1 level in adolescents with polycystic ovarian syndrome
Özgen, İ. T., Oruçlu, Ş., Selek, Ş., Kutlu, E., Guzel, G., & Cesur, Y. (2018) · Pediatrics International · doi:10.1111/ped.13761 · Cited by 24
Ciresi, A., Guarnotta, V., Campo, D., & Giordano, C. S. D. S. (2018) · International Journal of Endocrinology · doi:10.1155/2018/5421961 · Cited by 23
Li, M. H., Chen, W., Wang, L., Sun, J. L., Zhou, L., Shi, Y., Wang, C. H., Zhong, B. H., Shi, W. G., & Guo, Z. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255216 · Cited by 24
Calderón, B., Huerta, L., Galindo, J., Casbas, J. M. G., Escobar-Morreale, H. F., Martín‐Hidalgo, A., & Botella-Carretero, J. I. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03798-4 · Cited by 26
Gulsin, G. S., Brady, E. M., Swarbrick, D. J., Athithan, L., Henson, J. J., Baldry, E. L., McAdam, J., Marsh, A.-M., Parke, K. S., Wormleighton, J. V., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023207 · Cited by 24
Estándares SEA 2019 para el control global del riesgo cardiovascular
Mostaza, J. M., Pintó, X., Armario, P., Masana, L., Ascaso, J. F., Valdivielso, P., Velilla, T. A., Brea, Á., Calmarza, P., Cebollada, J., et al. (2019) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2019.03.004 · Cited by 36
Brock, J. M., Schmid, A., Karrasch, T., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.14040 · Cited by 24
Kwak, S. H., Hwang, Y., Won, J. C., Bae, J. C., Kim, H. J., Suh, S., Lee, E. Y., Lee, S., Kim, S., & Kim, J. H. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13882 · Cited by 24
Li, M., Mínguez‐Alarcón, L., Bellavia, A., Williams, P. L., James-Todd, T. M., Hauser, R. B., Chavarro, J. E., & Chiu, Y. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108729 · Cited by 24
Jansen, L. T., Suh, H., Adams, J. D., Sprong, C., Seal, A., Scott, D., Butts, C. L., Melander, O., Kirkland, T. W., Vanhaecke, T., et al. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz236 · Cited by 25
Dudi, P., Goyal, B., Saxena, V., Rabari, K., Mirza, A. A., Naithani, M., Kumar, T., & Goyal, R. (2019) · Journal of Laboratory Physicians · doi:10.4103/jlp.jlp_163_18 · Cited by 24
Cibičková, Ľ., Langová, K., Vaverkova, H., Lukeš, J., Cibiček, N., & Karásek, D. (2019) · Physiological Research · doi:10.33549/physiolres.934176 · Cited by 16
Fang, X., Xia, T., Xu, F., Wu, H., Ma, Z., Zhao, X., & Gu, X. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146511 · Cited by 23
Lee, G., Han, J. H., Maeng, H. J., & Lim, S. K. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes19042 · Cited by 26
Chang, Y., Bellettiere, J., Godbole, S. V., Keshavarz, S., Maestas, J. P., Unkart, J., Ervin, D., Allison, M., Rock, C. L., Patterson, R. E., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013403 · Cited by 24
Martín, M. Á., Robles‐Vera, I., Sánchez-Roncero, A., Escrivá, F., Pérez‐Vizcaíno, F., Duarte, J., Álvarez, C., & Fernández‐Millán, E. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108383 · Cited by 24
Aboulmagd, Y. M., El-Bahy, A. A. Z., Menze, E. T., Azab, S. S., & El‐Demerdash, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173224 · Cited by 26
Hernández‐Rodas, M. C., Rojas, P., Fernando Carrasco, N., Basfi-fer, K., Valenzuela, R., Codoceo, J., Inostroza, J., & Manuel Ruz, O. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126571 · Cited by 24
Thumann, B. F., Michels, N., Felsö, R., Hunsberger, M. L., Kaprio, J. A., Moreno, L. A., Siani, A., Tornaritis, M. J., Veidebaum, T., Henauw, S. D., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235049 · Cited by 23
Nonalcoholic fatty liver disease in males with low testosterone concentrations
Pοlyzos, S. A., Mousiolis, A. C., Mintziori, G., & Goulis, D. G. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.07.049 · Cited by 24
Liu, W., Zhang, Y., Chen, Q., Liu, S., Xu, W., Shang, W., Wang, L., & Yu, J. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4927403 · Cited by 26
HOMA-IR in acromegaly: a systematic review and meta-analysis
Biagetti, B., Aulinas, A., Casteràs, A., et al. (2020) · Pituitary · doi:10.1007/s11102-020-01092-6 · Cited by 24
Latorre-Millán, M., Rupérez, A. I., González‐Gil, E. M., Santaliestra-Pasías, A. M., Vázquez‐Cobela, R., Gil‐Campos, M., Aguilera, C. M., Gil, Á., Moreno, L. A., Leis, R., et al. (2020) · Nutrients · doi:10.3390/nu12113424 · Cited by 24
González-Salazar, L. E., Pichardo‐Ontiveros, E., Palacios‐González, B., Vigil‐Martínez, A., Granados‐Portillo, O., Guizar-Heredia, R., Flores‐López, A., Vera, I., Heredia-G-Cantón, P. K., Hernández-Gómez, K. G., et al. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02428-5 · Cited by 27
Chen, X., Deng, S., Sena, C., Zhou, C., & Thaker, V. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa900 · Cited by 27
Ho, J. H., Adam, S., Liu, Y., Azmi, S., Dhage, S. S., Syed, A. A., Ammori, B. J., Donn, R. P., Heald, A. H., Gibson, M., et al. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.12.002 · Cited by 24
Fibre Intake Is Associated with Cardiovascular Health in European Children
Larrosa, S., Luque, V., Grote, V., Closa‐Monasterolo, R., Ferré, N., Koletzko, B. V., Verduci, E., Gruszfeld, D., Xhonneux, A., & Escribano, J. (2020) · Nutrients · doi:10.3390/nu13010012 · Cited by 27
Jurkovičová, J., Hirošová, K., Vondrová, D., Samohýl, M., Štefániková, Z., Filová, A., Kachútová, I., Babjaková, J., & Argalášová, Ľ. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18030909 · Cited by 28
Metabolic syndrome and insulin resistance in pre-pubertal children with psoriasis
Caroppo, F., Galderisi, A., Ventura, L., & Fortina, A. B. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-020-03924-w · Cited by 25
Kautzky, A., Heneis, K., Stengg, K., Fröhlich, S., & Kautzky‐Willer, A. (2021) · Neuroendocrinology · doi:10.1159/000514484 · Cited by 26
Demirci, İ., Haymana, C., Candemir, B., Meric, C., Yuksel, B., Eser, M., Akın, O., Akın, Ş., Gulcelik, N. E., & Sonmez, A. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0019 · Cited by 25
Sedky, A. A., & Magdy, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119523 · Cited by 26
Wang, X., Ba, T., Cheng, Y., Zhang, P., & Chang, X. (2021) · Nutrition · doi:10.1016/j.nut.2021.111285 · Cited by 24
Metabolomics dissection of depression heterogeneity and related cardiometabolic risk
Alshehri, T., Mook‐Kanamori, D. O., van Dijk, K. W., Dinga, R., Penninx, B. W. J. H., Rosendaal, F. R., le Cessie, S., & Milaneschi, Y. (2021) · Psychological Medicine · doi:10.1017/s0033291721001471 · Cited by 25
Park, J., Koo, B. K., Kim, W. K., & Kim, W. (2021) · Hepatology International · doi:10.1007/s12072-021-10209-3 · Cited by 24
Henriksson, P., Sandborg, J., Söderström, E., Leppänen, M. H., Snekkenes, V., Blomberg, M. I., Ortega, F. B., & Löf, M. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00158-z · Cited by 24
HOMA indices as screening tests for cystic fibrosis-related diabetes
Toin, T., Reynaud, Q., Denis, A., et al. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.05.010 · Cited by 24
Ragi, M.-E. E., Haber, R., El-Masri, F., & Obeid, O. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521003238 · Cited by 26
Almohaimeed, H. M., Mohammedsaleh, Z. M., Batawi, A. H., Balgoon, M. J., Ramadan, O., Baz, H. A., Jaouni, S. K. A., & Ayuob, N. N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.727049 · Cited by 24
Dhanasekara, C. S., Nelson, A., Spradley, M., Wynn, A. G., Robohm-Leavitt, C., Shen, C., & Kahathuduwa, C. N. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.09.014 · Cited by 27
Martínez, C. G., Babió, N., Júlvez, J., Becerra‐Tomás, N., Martínez‐González, M. Á., Corella, D., Castañer, O., Romaguera, D., Vioqué, J., Alonso‐Gómez, Á. M., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.754347 · Cited by 26
Gao, H. Y., Song, R., Jiang, H., Zhang, W., & Han, S. (2021) · Nutrition · doi:10.1016/j.nut.2021.111558 · Cited by 24
Negrea, M. O., Neamtu, B. M., Dobrotă, I., Șofariu, C. R., Crișan, R.-M., Bacila, C. I., Domnariu, C. D., & Teodoru, M. (2021) · Applied Sciences · doi:10.3390/app112311565 · Cited by 27
Xiao, Q., Matthews, C. E., Playdon, M. C., & Bauer, C. (2021) · SLEEP · doi:10.1093/sleep/zsab291 · Cited by 26
Draganidis, D., Jamurtas, A. Z., Chondrogianni, N., Mastorakos, G. P., Jung, T., Grune, T., Papadopoulos, C., Παπανικολάου, Κ., Papassotiriou, I., Papaevgeniou, N., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8376915 · Cited by 30
Charatcharoenwitthaya, P., Tansakul, E., Chaiyasoot, K., Bandidniyamanon, W., & Charatcharoenwitthaya, N. (2021) · Nutrients · doi:10.3390/nu13124438 · Cited by 25
Crommen, S., Rheinwalt, K. P., Plamper, A., Simon, M., Rösler, D., Fimmers, R., Egert, S., & Metzner, C. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab392 · Cited by 27
Kim, K., Oh, T. J., Cho, H. C., Lee, Y. K., Ahn, C. H., Koo, B. K., Moon, J. H., Choi, S. H., & Jang, H. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-03870-z · Cited by 24
Association between sleep disordered breathing in early pregnancy and glucose metabolism
Sanapo, L., Bublitz, M. H., Bai, A., Mehta, N., Messerlian, G. M., Catalano, P., & Bourjeily, G. (2022) · SLEEP · doi:10.1093/sleep/zsab281 · Cited by 25
Dündar, İ., & Akıncı, A. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0271 · Cited by 24
Serhiyenko, V. A., Serhiyenko, A. A., Sehin, V. B., & Serhiyenko, L. M. (2022) · Vessel Plus · doi:10.20517/2574-1209.2021.83 · Cited by 24
Zhu, S., Liu, C., Zhao, C., Chen, G., Meng, S., Ma, H., Xiang, M., & Xie, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.874846 · Cited by 25
Baumert, B. O., Goodrich, J. A., Hu, X. Y., Walker, D. I., Alderete, T. L., Chen, Z., Valvi, D., Rock, S., Berhane, K. T., Gilliland, F. D., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113296 · Cited by 24
Breath biomarkers of insulin resistance in pre-diabetic Hispanic adolescents with obesity
Khan, M. S., Cuda, S. E., Karere, G. M., Cox, L. A., & Bishop, A. C. (2022) · Scientific Reports · doi:10.1038/s41598-021-04072-3 · Cited by 29
Yang, X., Gao, Z., Huang, X., Zhang, M., Shi, Y., & Chen, Z. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02685-8 · Cited by 24
Liu, N., Luo, X., Li, P., & Xiong, W. (2022) · Andrology · doi:10.1111/andr.13207 · Cited by 24
Fernández‐García, J. C., Barrios‐Rodríguez, R., Asenjo‐Plaza, M., Ramos‐Molina, B., Molina‐Vega, M., Guzmán-Guzmán, A., Moreno-León, L., Yubero‐Serrano, E. M., Ríus, F., Valdés, S., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155290 · Cited by 27
Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patients
Meyer, N. M. T., Kabisch, S., Dambeck, U., Honsek, C., Kemper, M., Gerbracht, C., Arafat, A. M., Birkenfeld, A. L., Schwarz, P. E. H., Machann, J., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0034 · Cited by 24
Mohammadi, S., Lotfi, K., Mirzaei, S., Asadi, A., Akhlaghi, M., & Saneei, P. (2022) · Nutrition Journal · doi:10.1186/s12937-022-00806-9 · Cited by 24
Raets, L., Minschart, C., den Bruel, A. V., den Bogaert, E. V., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175016 · Cited by 27
Biomarkers in metabolic syndrome
Cho, Y. H., Lee, Y., Choi, J. I., Lee, S. R., & Lee, S. Y. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.07.003 · Cited by 26
Sandborg, J., Migueles, J. H., Söderström, E., Blomberg, M. I., Henriksson, P., & Löf, M. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002996 · Cited by 28
Camajani, E., Feraco, A., Proietti, S., Basciani, S., Barrea, L., Armani, A., Lombardo, M., Gnessi, L., & Caprio, M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.955024 · Cited by 23
Kim, Y., Lee, Y., Lee, M. N., Nah, J., Yun, N., Wu, D., & Pae, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1054875 · Cited by 23
Hénin, G., Lanthier, N., & Dahlqvist, G. (2022) · Acta gastro-enterologica belgica · doi:10.51821/85.4.10899 · Cited by 26
Specific Alteration of Branched-Chain Amino Acid Profile in Polycystic Ovary Syndrome
Paczkowska, K., Rachoń, D., Berg, A., Rybka, J., Kapczyńska, K., Bolanowski, M., & Daroszewski, J. (2023) · Biomedicines · doi:10.3390/biomedicines11010108 · Cited by 25
Tipici, B. E., Coşkunpınar, E. M., Altunkanat, D., Çağatay, P., Ömer, B., Palanduz, Ş., Satman, İ., & Aral, F. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03139-3 · Cited by 25
Adherence to Mediterranean Diet: Any Association with NAFLD?
Barrea, L., Verde, L., Savastano, S., Colao, A., & Muscogiuri, G. (2023) · Antioxidants · doi:10.3390/antiox12071318 · Cited by 26
Kowalski, K., Szponar, B., Bochen, P., Żebrowska-Różańska, P., Łaczmański, Ł., Samochowiec, J., & Misiak, B. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.07.042 · Cited by 25
Skudder‐Hill, L., Sequeira, I. R., Ko, J., Cho, J., Poppitt, S. D., & Petrov, M. S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15233 · Cited by 26
Okawa, M. C., Tuska, R., Lightbourne, M., Abel, B. S., Walter, M. F., Dai, Y., Cochran, E. K., & Brown, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad491 · Cited by 24
Retnakaran, R. R., Ye, C., Kramer, C. K., Hanley, A. J., Connelly, P. W., Sermer, M., & Zinman, B. (2023) · Diabetologia · doi:10.1007/s00125-023-05994-5 · Cited by 29
Chen, H., Liu, Y., Liu, D., Liang, Y., Zhu, Z., Dong, K., Li, H., Bao, Y., Wu, J., Hou, X., et al. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad069 · Cited by 24
Núñez‐Sánchez, M. Á., Martínez‐Sánchez, M. A., Martínez‐Montoro, J. I., Román, A. B., García, E. M., Fernández-Ruiz, V. E., Ferrer‐Gómez, M., Martínez, C. M., Śledziński, T., Frutos, M. D., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae028 · Cited by 25
Bruns, A., Greupner, T., Nebl, J., & Hahn, A. (2024) · BMC Nutrition · doi:10.1186/s40795-024-00839-9 · Cited by 28
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
